APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biodegradable Medical Polymer

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biodegradable Medical Polymer Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchBiodegradable Medical Polymer Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Biodegradable Medical Polymer Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Biodegradable Medical Polymer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biodegradable Medical Polymer Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Biodegradable Medical Polymer Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Biodegradable Medical Polymer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biodegradable Medical Polymer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biodegradable Medical Polymer market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biodegradable Medical Polymer market include Poly-Med, PCAS, Mitsui Chemicals, KLS Martin, Evonik, DSM and Corbion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biodegradable Medical Polymer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biodegradable Medical Polymer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biodegradable Medical Polymer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biodegradable Medical Polymer market size, projected growth trends, production technologies, key applications, and end-use industries.

Biodegradable Medical Polymer Segment by Company

Poly-Med

PCAS

Mitsui Chemicals

KLS Martin

Evonik

DSM

Corbion

Biodegradable Medical Polymer Segment by Type

Polysaccharides

Polycaprolactone (PCL)

Polylactic Acid (PLA)

PLGA

Polyglycolic Acid (PGA)

Biodegradable Medical Polymer Segment by Application

Drug Delivery

Orthopedics

Others

Biodegradable Medical Polymer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biodegradable Medical Polymer status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biodegradable Medical Polymer market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biodegradable Medical Polymer significant trends, drivers, influence factors in global and regions.

6. To analyze Biodegradable Medical Polymer competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Medical Polymer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Medical Polymer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Medical Polymer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biodegradable Medical Polymer market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biodegradable Medical Polymer industry.

Chapter 3: Detailed analysis of Biodegradable Medical Polymer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biodegradable Medical Polymer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biodegradable Medical Polymer in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biodegradable Medical Polymer Industry Trends Table 2. Biodegradable Medical Polymer Industry Drivers Table 3. Biodegradable Medical Polymer Industry Opportunities and Challenges Table 4. Biodegradable Medical Polymer Industry Restraints Table 5. Global Biodegradable Medical Polymer Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biodegradable Medical Polymer Revenue Share by Company (2021-2026) Table 7. Global Biodegradable Medical Polymer Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Biodegradable Medical Polymer Sales Volume Share by Company (2021-2026) Table 9. Global Biodegradable Medical Polymer Average Price (US$/ton) of Company (2021-2026) Table 10. Global Biodegradable Medical Polymer Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biodegradable Medical Polymer Key Company Manufacturing Base & Headquarters Table 12. Global Biodegradable Medical Polymer Company, Product Type & Application Table 13. Global Biodegradable Medical Polymer Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biodegradable Medical Polymer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Polysaccharides Table 18. Significant Companies of Polycaprolactone (PCL) Table 19. Significant Companies of Polylactic Acid (PLA) Table 20. Significant Companies of PLGA Table 21. Significant Companies of Polyglycolic Acid (PGA) Table 22. Global Biodegradable Medical Polymer Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 23. Global Biodegradable Medical Polymer Sales Volume by Type (2021-2026) & (k tons) Table 24. Global Biodegradable Medical Polymer Sales Volume by Type (2027-2032) & (k tons) Table 25. Global Biodegradable Medical Polymer Sales Volume Share by Type (2021-2026) Table 26. Global Biodegradable Medical Polymer Sales Volume Share by Type (2027-2032) Table 27. Global Biodegradable Medical Polymer Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biodegradable Medical Polymer Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Biodegradable Medical Polymer Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Biodegradable Medical Polymer Sales Value Share by Type (2021-2026) Table 31. Global Biodegradable Medical Polymer Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Drug Delivery Table 33. Significant Companies of Orthopedics Table 34. Significant Companies of Others Table 35. Global Biodegradable Medical Polymer Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 36. Global Biodegradable Medical Polymer Sales Volume by Application (2021-2026) & (k tons) Table 37. Global Biodegradable Medical Polymer Sales Volume by Application (2027-2032) & (k tons) Table 38. Global Biodegradable Medical Polymer Sales Volume Share by Application (2021-2026) Table 39. Global Biodegradable Medical Polymer Sales Volume Share by Application (2027-2032) Table 40. Global Biodegradable Medical Polymer Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Biodegradable Medical Polymer Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Biodegradable Medical Polymer Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Biodegradable Medical Polymer Sales Value Share by Application (2021-2026) Table 44. Global Biodegradable Medical Polymer Sales Value Share by Application (2027-2032) Table 45. Global Biodegradable Medical Polymer Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 46. Global Biodegradable Medical Polymer Sales by Region (2021-2026) & (k tons) Table 47. Global Biodegradable Medical Polymer Sales Market Share by Region (2021-2026) Table 48. Global Biodegradable Medical Polymer Sales by Region (2027-2032) & (k tons) Table 49. Global Biodegradable Medical Polymer Sales Market Share by Region (2027-2032) Table 50. Global Biodegradable Medical Polymer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Biodegradable Medical Polymer Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Biodegradable Medical Polymer Sales Value Share by Region (2021-2026) Table 53. Global Biodegradable Medical Polymer Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Biodegradable Medical Polymer Sales Value Share by Region (2027-2032) Table 55. Global Biodegradable Medical Polymer Market Average Price (US$/ton) by Region (2021-2026) Table 56. Global Biodegradable Medical Polymer Market Average Price (US$/ton) by Region (2027-2032) Table 57. Global Biodegradable Medical Polymer Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 58. Global Biodegradable Medical Polymer Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Biodegradable Medical Polymer Sales by Country (2021-2026) & (k tons) Table 60. Global Biodegradable Medical Polymer Sales Market Share by Country (2021-2026) Table 61. Global Biodegradable Medical Polymer Sales by Country (2027-2032) & (k tons) Table 62. Global Biodegradable Medical Polymer Sales Market Share by Country (2027-2032) Table 63. Global Biodegradable Medical Polymer Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Biodegradable Medical Polymer Sales Value Market Share by Country (2021-2026) Table 65. Global Biodegradable Medical Polymer Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Biodegradable Medical Polymer Sales Value Market Share by Country (2027-2032) Table 67. Poly-Med Company Information Table 68. Poly-Med Business Overview Table 69. Poly-Med Biodegradable Medical Polymer Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 70. Poly-Med Biodegradable Medical Polymer Product Portfolio Table 71. Poly-Med Recent Development Table 72. PCAS Company Information Table 73. PCAS Business Overview Table 74. PCAS Biodegradable Medical Polymer Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. PCAS Biodegradable Medical Polymer Product Portfolio Table 76. PCAS Recent Development Table 77. Mitsui Chemicals Company Information Table 78. Mitsui Chemicals Business Overview Table 79. Mitsui Chemicals Biodegradable Medical Polymer Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Mitsui Chemicals Biodegradable Medical Polymer Product Portfolio Table 81. Mitsui Chemicals Recent Development Table 82. KLS Martin Company Information Table 83. KLS Martin Business Overview Table 84. KLS Martin Biodegradable Medical Polymer Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. KLS Martin Biodegradable Medical Polymer Product Portfolio Table 86. KLS Martin Recent Development Table 87. Evonik Company Information Table 88. Evonik Business Overview Table 89. Evonik Biodegradable Medical Polymer Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Evonik Biodegradable Medical Polymer Product Portfolio Table 91. Evonik Recent Development Table 92. DSM Company Information Table 93. DSM Business Overview Table 94. DSM Biodegradable Medical Polymer Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. DSM Biodegradable Medical Polymer Product Portfolio Table 96. DSM Recent Development Table 97. Corbion Company Information Table 98. Corbion Business Overview Table 99. Corbion Biodegradable Medical Polymer Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Corbion Biodegradable Medical Polymer Product Portfolio Table 101. Corbion Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Biodegradable Medical Polymer Distributors List Table 105. Biodegradable Medical Polymer Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Biodegradable Medical Polymer Product Image Figure 2. Global Biodegradable Medical Polymer Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biodegradable Medical Polymer Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biodegradable Medical Polymer Sales (2021-2032) & (k tons) Figure 5. Global Biodegradable Medical Polymer Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Biodegradable Medical Polymer Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Polysaccharides Image Figure 10. Polycaprolactone (PCL) Image Figure 11. Polylactic Acid (PLA) Image Figure 12. PLGA Image Figure 13. Polyglycolic Acid (PGA) Image Figure 14. Global Biodegradable Medical Polymer Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 15. Global Biodegradable Medical Polymer Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Biodegradable Medical Polymer Sales Volume Share by Type (2021-2032) Figure 17. Global Biodegradable Medical Polymer Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biodegradable Medical Polymer Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Biodegradable Medical Polymer Sales Value Share by Type (2021-2032) Figure 20. Drug Delivery Image Figure 21. Orthopedics Image Figure 22. Others Image Figure 23. Global Biodegradable Medical Polymer Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Biodegradable Medical Polymer Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Biodegradable Medical Polymer Sales Volume Share by Application (2021-2032) Figure 26. Global Biodegradable Medical Polymer Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Biodegradable Medical Polymer Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Biodegradable Medical Polymer Sales Value Share by Application (2021-2032) Figure 29. Global Biodegradable Medical Polymer Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 30. Global Biodegradable Medical Polymer Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Biodegradable Medical Polymer Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Biodegradable Medical Polymer Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Biodegradable Medical Polymer Sales Value (2021-2032) & (US$ Million) Figure 34. North America Biodegradable Medical Polymer Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Biodegradable Medical Polymer Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Biodegradable Medical Polymer Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Biodegradable Medical Polymer Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Biodegradable Medical Polymer Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Biodegradable Medical Polymer Sales Value (2021-2032) & (US$ Million) Figure 40. South America Biodegradable Medical Polymer Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Biodegradable Medical Polymer Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Biodegradable Medical Polymer Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Biodegradable Medical Polymer Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Biodegradable Medical Polymer Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Polysaccharides
  • Polycaprolactone (PCL)
  • Polylactic Acid (PLA)
  • PLGA
  • Polyglycolic Acid (PGA)
Applications
  • Drug Delivery
  • Orthopedics
  • Others
Companies covered
  • Poly-Med
  • PCAS
  • Mitsui Chemicals
  • KLS Martin
  • Evonik
  • DSM
  • Corbion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biodegradable Medical Polymer Sales Value (2021-2032)
  4. 1.2.2 Global Biodegradable Medical Polymer Sales Volume (2021-2032)
  5. 1.2.3 Global Biodegradable Medical Polymer Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biodegradable Medical Polymer Market Dynamics
  1. 2.1 Biodegradable Medical Polymer Industry Trends
  2. 2.2 Biodegradable Medical Polymer Industry Drivers
  3. 2.3 Biodegradable Medical Polymer Industry Opportunities and Challenges
  4. 2.4 Biodegradable Medical Polymer Industry Restraints
3 Biodegradable Medical Polymer Market by Company
  1. 3.1 Global Biodegradable Medical Polymer Company Revenue Ranking in 2025
  2. 3.2 Global Biodegradable Medical Polymer Revenue by Company (2021-2026)
  3. 3.3 Global Biodegradable Medical Polymer Sales Volume by Company (2021-2026)
  4. 3.4 Global Biodegradable Medical Polymer Average Price by Company (2021-2026)
  5. 3.5 Global Biodegradable Medical Polymer Company Ranking (2024-2026)
  6. 3.6 Global Biodegradable Medical Polymer Company Manufacturing Base and Headquarters
  7. 3.7 Global Biodegradable Medical Polymer Company Product Type and Application
  8. 3.8 Global Biodegradable Medical Polymer Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biodegradable Medical Polymer Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biodegradable Medical Polymer Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biodegradable Medical Polymer Market by Type
  1. 4.1 Biodegradable Medical Polymer Type Introduction
  2. 4.1.1 Polysaccharides
  3. 4.1.2 Polycaprolactone (PCL)
  4. 4.1.3 Polylactic Acid (PLA)
  5. 4.1.4 PLGA
  6. 4.1.5 Polyglycolic Acid (PGA)
  7. 4.2 Global Biodegradable Medical Polymer Sales Volume by Type
  8. 4.2.1 Global Biodegradable Medical Polymer Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Biodegradable Medical Polymer Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Biodegradable Medical Polymer Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Biodegradable Medical Polymer Sales Value by Type
  12. 4.3.1 Global Biodegradable Medical Polymer Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Biodegradable Medical Polymer Sales Value by Type (2021-2032)
  14. 4.3.3 Global Biodegradable Medical Polymer Sales Value Share by Type (2021-2032)
5 Biodegradable Medical Polymer Market by Application
  1. 5.1 Biodegradable Medical Polymer Application Introduction
  2. 5.1.1 Drug Delivery
  3. 5.1.2 Orthopedics
  4. 5.1.3 Others
  5. 5.2 Global Biodegradable Medical Polymer Sales Volume by Application
  6. 5.2.1 Global Biodegradable Medical Polymer Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biodegradable Medical Polymer Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Biodegradable Medical Polymer Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Biodegradable Medical Polymer Sales Value by Application
  10. 5.3.1 Global Biodegradable Medical Polymer Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Biodegradable Medical Polymer Sales Value by Application (2021-2032)
  12. 5.3.3 Global Biodegradable Medical Polymer Sales Value Share by Application (2021-2032)
6 Biodegradable Medical Polymer Regional Sales and Value Analysis
  1. 6.1 Global Biodegradable Medical Polymer Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biodegradable Medical Polymer Sales by Region (2021-2032)
  3. 6.2.1 Global Biodegradable Medical Polymer Sales by Region: 2021-2026
  4. 6.2.2 Global Biodegradable Medical Polymer Sales by Region (2027-2032)
  5. 6.3 Global Biodegradable Medical Polymer Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biodegradable Medical Polymer Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biodegradable Medical Polymer Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biodegradable Medical Polymer Sales Value by Region (2027-2032)
  9. 6.5 Global Biodegradable Medical Polymer Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biodegradable Medical Polymer Sales Value (2021-2032)
  12. 6.6.2 North America Biodegradable Medical Polymer Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biodegradable Medical Polymer Sales Value (2021-2032)
  15. 6.7.2 Europe Biodegradable Medical Polymer Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biodegradable Medical Polymer Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biodegradable Medical Polymer Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biodegradable Medical Polymer Sales Value (2021-2032)
  21. 6.9.2 South America Biodegradable Medical Polymer Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biodegradable Medical Polymer Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biodegradable Medical Polymer Sales Value Share by Country, 2025 VS 2032
7 Biodegradable Medical Polymer Country-level Sales and Value Analysis
  1. 7.1 Global Biodegradable Medical Polymer Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biodegradable Medical Polymer Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biodegradable Medical Polymer Sales by Country (2021-2032)
  4. 7.3.1 Global Biodegradable Medical Polymer Sales by Country (2021-2026)
  5. 7.3.2 Global Biodegradable Medical Polymer Sales by Country (2027-2032)
  6. 7.4 Global Biodegradable Medical Polymer Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biodegradable Medical Polymer Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biodegradable Medical Polymer Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biodegradable Medical Polymer Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biodegradable Medical Polymer Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biodegradable Medical Polymer Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Poly-Med
  2. 8.1.1 Poly-Med Company Information
  3. 8.1.2 Poly-Med Business Overview
  4. 8.1.3 Poly-Med Biodegradable Medical Polymer Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Poly-Med Biodegradable Medical Polymer Product Portfolio
  6. 8.1.5 Poly-Med Recent Developments
  7. 8.2 PCAS
  8. 8.2.1 PCAS Company Information
  9. 8.2.2 PCAS Business Overview
  10. 8.2.3 PCAS Biodegradable Medical Polymer Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 PCAS Biodegradable Medical Polymer Product Portfolio
  12. 8.2.5 PCAS Recent Developments
  13. 8.3 Mitsui Chemicals
  14. 8.3.1 Mitsui Chemicals Company Information
  15. 8.3.2 Mitsui Chemicals Business Overview
  16. 8.3.3 Mitsui Chemicals Biodegradable Medical Polymer Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mitsui Chemicals Biodegradable Medical Polymer Product Portfolio
  18. 8.3.5 Mitsui Chemicals Recent Developments
  19. 8.4 KLS Martin
  20. 8.4.1 KLS Martin Company Information
  21. 8.4.2 KLS Martin Business Overview
  22. 8.4.3 KLS Martin Biodegradable Medical Polymer Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 KLS Martin Biodegradable Medical Polymer Product Portfolio
  24. 8.4.5 KLS Martin Recent Developments
  25. 8.5 Evonik
  26. 8.5.1 Evonik Company Information
  27. 8.5.2 Evonik Business Overview
  28. 8.5.3 Evonik Biodegradable Medical Polymer Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Evonik Biodegradable Medical Polymer Product Portfolio
  30. 8.5.5 Evonik Recent Developments
  31. 8.6 DSM
  32. 8.6.1 DSM Company Information
  33. 8.6.2 DSM Business Overview
  34. 8.6.3 DSM Biodegradable Medical Polymer Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 DSM Biodegradable Medical Polymer Product Portfolio
  36. 8.6.5 DSM Recent Developments
  37. 8.7 Corbion
  38. 8.7.1 Corbion Company Information
  39. 8.7.2 Corbion Business Overview
  40. 8.7.3 Corbion Biodegradable Medical Polymer Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Corbion Biodegradable Medical Polymer Product Portfolio
  42. 8.7.5 Corbion Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biodegradable Medical Polymer Value Chain Analysis
  2. 9.1.1 Biodegradable Medical Polymer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biodegradable Medical Polymer Sales Mode & Process
  6. 9.2 Biodegradable Medical Polymer Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biodegradable Medical Polymer Distributors
  9. 9.2.3 Biodegradable Medical Polymer Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst